Simulations Plus develops pharmaceutical simulation software that helps scientists to develop new drugs from chemical's biological structures...
Read moreSimulations Plus develops pharmaceutical simulation software that helps scientists to develop new drugs from chemical's biological structures...
Read moreAnnual Revenue
$53.5M
Simulations Plus's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 52.5M. Over the last four quarters, Simulations Plus's revenue has decreased by 19.1%. Specifically, in Q4 2022's revenue was $12M; in Q3 2022, it was $11.7M; in Q2 2022, it was $15M; in Q1 2022, Simulations Plus's revenue was $14.8M.